Skip to main content
Top

PharmacoEconomics

Issue 11/2011

Content (7 Articles)

Methodological Note

The Importance of the Comparator in Economic Evaluations

Mattias Neyt, Hans Van Brabandt

Current Opinion

Utility Estimation in Chronic Obstructive Pulmonary Disease

Jennifer Petrillo, Floortje van Nooten, Paul Jones, Maureen Rutten-van MÖlken

Practical Application

Sample Size Determination for Cost-Effectiveness Trials

Andrew R. Willan

Review Article

Denosumab for the Prevention of Osteoporotic Fractures in Post-Menopausal Women

Graham Scotland, Norman Waugh, Pamela Royle, Paul McNamee, Rob Henderson, Rosemary Hollick

Original Research Article

Willingness to Pay for Adverse Drug Event Regulatory Actions

Jacoline Bouvy, Just Weemers, Huub Schellekens, Marc Koopmanschap

Original Research Aticle

Patient Benefit-Risk Preferences for Targeted Agents in the Treatment of Renal Cell Carcinoma

Ateesha F. Mohamed, A. Brett Hauber, Maureen P. Neary

Adis Pharmacoeconomic Drug Evaluation

Rotavirus Vaccine RIX4414 (Rotarix™)

Greg L. Plosker